Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-06-07, Stock:NVO, The news for the past five days is as follows:
2021-05-28: NEWS1: Is Novo Nordisk A/S (NVO) A Smart Long-Term Buy?.NEWS2: Novo Nordisk resubmits once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes for US regulatory approval.
2021-06-01: NEWS1: Novo Nordisk (NVO) Inks Deal to Develop Heart Failure Treatment.
2021-06-02: NEWS1: 15 Most Valuable Pharmaceutical Companies In The World.
2021-06-03: nan
2021-06-04: NEWS1: FDA approves Novo Nordisk’s obesity drug Wegovy, which helped people cut weight 15%.NEWS2: UPDATE 2-U.S. FDA approves Novo Nordisk's semaglutide as obesity treatment.NEWS3: Wegovy™ (semaglutide 2.4 mg), the first and only once-weekly GLP-1 therapy for weight management, approved in the US.

Answer: Rise